0001849521-24-000004.txt : 20240603
0001849521-24-000004.hdr.sgml : 20240603
20240603173057
ACCESSION NUMBER: 0001849521-24-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240603
DATE AS OF CHANGE: 20240603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandford Nicole
CENTRAL INDEX KEY: 0001849521
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34810
FILM NUMBER: 241015120
BUSINESS ADDRESS:
BUSINESS PHONE: 203-969-5688
MAIL ADDRESS:
STREET 1: 12117 BEE CAVES RD BLDG 3
STREET 2: STE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aspira Women's Health Inc.
CENTRAL INDEX KEY: 0000926617
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330595156
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
BUSINESS PHONE: 512-519-0400
MAIL ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
FORMER COMPANY:
FORMER CONFORMED NAME: VERMILLION, INC.
DATE OF NAME CHANGE: 20070824
FORMER COMPANY:
FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC
DATE OF NAME CHANGE: 20000316
FORMER COMPANY:
FORMER CONFORMED NAME: ABIOTIC SYSTEMS
DATE OF NAME CHANGE: 19950407
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-05-31
0
0000926617
Aspira Women's Health Inc.
AWH
0001849521
Sandford Nicole
C/O ASPIRA WOMEN'S HEALTH INC.
12117 BEE CAVES RD BLDG 3-100
AUSTIN
TX
78738
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-05-31
4
P
0
9493
2.42
A
70596
D
The purchase reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.34 to $2.45 per share. The reporting person undertakes to provide to AWH, any security holder of AWH or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Nicole Sandford
2024-06-03